Bairashevskaia AV, Belogubova SY, Kondratiuk MR, Rudnova DS, Sologova SS, Tereshkina OI, Avakyan EI (2022) Update of Takotsubo cardiomyopathy: present experience and outlook for the future. Int J Cardiol Heart Vasc 39:100990

PubMed  PubMed Central  Google Scholar 

Bauer S, Hezinger L, Rexhepi F, Ramanathan S, Kufer TA (2023) NOD-like receptors-emerging links to obesity and associated morbidities. Int J Mol Sci 24:8595

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bertaggia Calderara D, Aliotta A, Zermatten MG, Kröll D, Stirnimann G, Alberio L (2020) Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters. Thromb Res 187:91–102

Article  PubMed  CAS  Google Scholar 

Brown SM, Larsen NK, Thankam FG, Agrawal DK (2021) Regulatory role of cardiomyocyte metabolism via AMPK activation in modulating atrial structural, contractile, and electrical properties following atrial fibrillation. Can J Physiol Pharmacol 99:36–41

Article  PubMed  CAS  Google Scholar 

Butova X, Myachina T, Simonova R, Kochurova A, Mukhlynina E, Kopylova G, Shchepkin D, Khokhlova A (2023) The inter-chamber differences in the contractile function between left and right atrial cardiomyocytes in atrial fibrillation in rats. Front Cardiovasc Med 10:1203093

Article  PubMed  PubMed Central  CAS  Google Scholar 

Centuori SM, Bauman JE (2022) c-Met signaling as a therapeutic target in head and neck cancer. Cancer J 28:346–353

Article  PubMed  CAS  Google Scholar 

Chitongo PB, Roberts LN, Yang L, Patel RK, Lyall R, Luxton R, Aylwin SJB, Arya R (2017) Visceral adiposity is an independent determinant of hypercoagulability as measured by thrombin generation in morbid obesity. TH Open 1:e146–e154

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cho S, Ying F, Sweeney G (2023) Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease. Biomed J 46:100624

Article  PubMed  PubMed Central  CAS  Google Scholar 

Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ Jr (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95:2979–2984

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dai Y, Siemann DW (2012) Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607. BMC Cancer 12:198

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dangwal S, Rauch BH, Gensch T, Dai L, Bretschneider E, Vogelaar CF, Schrör K, Rosenkranz AC (2011) High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 31:624–633

Article  PubMed  CAS  Google Scholar 

Dobrev D, Heijman J, Hiram R, Li N, Nattel S (2023) Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. Nat Rev Cardiol 20:145–167

Article  PubMed  CAS  Google Scholar 

Dong X, Qin J, Ma J, Zeng Q, Zhang H, Zhang R, Liu C, Xu C, Zhang S, Huang S, Chen L (2019) BAFF inhibits autophagy promoting cell proliferation and survival by activating Ca(2+)-CaMKII-dependent Akt/mTOR signaling pathway in normal and neoplastic B-lymphoid cells. Cell Signal 53:68–79

Article  PubMed  CAS  Google Scholar 

Fan X, Zhou J, Yan X, Bi X, Liang J, Lu S, Luo L, Zhou D, Yin Z (2021) Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway. Life Sci 275:119355

Article  PubMed  CAS  Google Scholar 

Fender AC, Rauch BH, Geisler T, Schror K (2017) Protease-activated receptor PAR-4: an inducible switch between thrombosis and vascular inflammation? Thromb Haemost 117:2013–2025

Article  PubMed  Google Scholar 

Fender AC, Wakili R, Dobrev D (2019) Straight to the heart: pleiotropic antiarrhythmic actions of oral anticoagulants. Pharmacol Res 145:104257

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fender AC, Kleeschulte S, Stolte S, Leineweber K, Kamler M, Bode J, Li N, Dobrev D (2020) Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart. Basic Res Cardiol 115:10

Article  PubMed  PubMed Central  Google Scholar 

Fischer OM, Giordano S, Comoglio PM, Ullrich A (2004) Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J Biol Chem 279:28970–28978

Article  PubMed  CAS  Google Scholar 

Fleischer M, Szepanowski RD, Pesara V, Bihorac JS, Oehler B, Dobrev D, Kleinschnitz C, Fender AC (2024) Direct neuronal protection by the protease-activated receptor PAR4 antagonist ML354 after experimental stroke in mice. Br J Pharmacol 181(18):3364–3379. https://doi.org/10.1111/bph.16415

Article  PubMed  CAS  Google Scholar 

Gawałko M, Saljic A, Li N, Abu-Taha I, Jespersen T, Linz D, Nattel S, Heijman J, Fender A, Dobrev D (2023) Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance. Cardiovasc Res 119:614–630

Article  PubMed  Google Scholar 

Gieseler F, Ungefroren H, Settmacher U, Hollenberg MD, Kaufmann R (2013) Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact. Cell Commun Signal 11:86

Article  PubMed  PubMed Central  CAS  Google Scholar 

Heijman J, Muna AP, Veleva T, Molina CE, Sutanto H, Tekook M, Wang Q, Abu-Taha IH, Gorka M, Künzel S, El-Armouche A, Reichenspurner H, Kamler M, Nikolaev V, Ravens U, Li N, Nattel S, Wehrens XHT, Dobrev D (2020) Atrial myocyte NLRP3/CaMKII nexus forms a substrate for postoperative atrial fibrillation. Circ Res 127:1036–1055

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hsu J, Hanna P, Van Wagoner DR, Barnard J, Serre D, Chung MK, Smith JD (2012) Whole genome expression differences in human left and right atria ascertained by RNA sequencing. Circ Cardiovasc Genet 5:327–335

Article  PubMed  CAS  Google Scholar 

Jin F, Lin Y, Yuan W, Wu S, Yang M, Ding S, Liu J, Chen Y (2024) Recent advances in c-Met-based dual inhibitors in the treatment of cancers. Eur J Med Chem 272:116477

Article  PubMed  CAS  Google Scholar 

Kahr PC, Piccini I, Fabritz L, Greber B, Schöler H, Scheld HH, Hoffmeier A, Brown NA, Kirchhof P (2011) Systematic analysis of gene expression differences between left and right atria in different mouse strains and in human atrial tissue. PLoS One 6:e26389

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kleeschulte S, Jerrentrup J, Gorski D, Schmitt J, Fender AC (2018) Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose: PAR-4 in cardiac fibroblasts. Int J Cardiol 252:163–166

Article  PubMed  Google Scholar 

Kleeschulte S, Fischinger V, Öhlke L, Bode J, Kamler M, Dobrev D, Grandoch M, Fender AC (2024) The thrombin receptor PAR4 supports visceral adipose tissue inflammation. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-024-03097-5

Kudo M, Morimoto M, Moriguchi M, Izumi N, Takayama T, Yoshiji H, Hino K, Oikawa T, Chiba T, Motomura K, Kato J, Yasuchika K, Ido A, Sato T, Nakashima D, Ueshima K, Ikeda M, Okusaka T, Tamura K, Furuse J (2020) A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma. Cancer Sci 111:3759–3769

Article  PubMed  PubMed Central  CAS  Google Scholar 

Leo C, Sala V, Morello M, Chiribiri A, Riess I, Mancardi D, Schiaffino S, Ponzetto C, Crepaldi T (2011) Activated Met signalling in the developing mouse heart leads to cardiac disease. PLoS One 6:e14675

Article